(Q43952320)

English

Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation rates

scientific article published in June 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation rates (English)

1 reference

Europe PubMed Central

28 November 2017

Plasmodium falciparum

0 references

malaria transmission

0 references

1 reference

based on heuristic

inferred from title

malaria vaccine

1 reference

based on heuristic

inferred from title

8

object named as

Tanner M

1 reference

Europe PubMed Central

28 November 2017

author name string

Kitua AY

1

1 reference

Europe PubMed Central

28 November 2017

Urassa H

2

1 reference

Europe PubMed Central

28 November 2017

Wechsler M

3

1 reference

Europe PubMed Central

28 November 2017

Smith T

4

1 reference

Europe PubMed Central

28 November 2017

Vounatsou P

5

1 reference

Europe PubMed Central

28 November 2017

Weiss NA

6

1 reference

Europe PubMed Central

28 November 2017

Alonso PL

7

1 reference

Europe PubMed Central

28 November 2017

publication date

1 June 1999

1 reference

Europe PubMed Central

28 November 2017

Parasite Immunology

1 reference

Europe PubMed Central

28 November 2017

21

1 reference

Europe PubMed Central

28 November 2017

6

1 reference

Europe PubMed Central

28 November 2017

307-317

1 reference

Europe PubMed Central

28 November 2017

Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Gamma-globulin and acquired immunity to human malaria.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Malarial circumsporozoite protein is a novel gene delivery vehicle to primary hepatocyte cultures and cultured cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Milk diet, p-aminobenzoic acid, and malaria (P. berghei); preliminary communication.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

A second region recognized by the protective monoclonal antibody 5C10/66 in the precursor to the major merozoite surface antigen of Plasmodium chabaudi adami.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Suppression of malaria (P. berghei) by milk.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Direct access to serum macromolecules by intraerythrocytic malaria parasites

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Relationships between maternal malaria and malarial immune responses in mothers and neonates

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Autoimmume and polyclonal B cell responses during murine malaria

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

A seroepidemiological study to evaluate the role of passive maternal immunity to malaria in infants

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Combating malaria morbidity and mortality by reducing transmission

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00230.X

21 January 2018

Identifiers

10.1046/J.1365-3024.1999.00230.X

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43952320&oldid=2104605685"